Filing Details
- Accession Number:
- 0000891293-10-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-02 13:00:00
- Reporting Period:
- 2010-06-30
- Filing Date:
- 2010-07-02
- Accepted Time:
- 2010-07-02 19:19:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cell Therapeutics Inc | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1041084 | Phd M Phillip Nudelman | 501 Elliott Ave West Suite 400 Seattle WA 98119 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-06-30 | 200 | $0.38 | 1,076,106 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 600 | $0.38 | 1,075,506 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 2,300 | $0.38 | 1,073,206 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 4,460 | $0.39 | 1,068,746 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 11,400 | $0.39 | 1,057,346 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 5,640 | $0.39 | 1,051,706 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 9,600 | $0.39 | 1,042,106 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 900 | $0.39 | 1,041,206 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 3,800 | $0.39 | 1,037,406 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 400 | $0.39 | 1,037,006 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-06-30 | 700 | $0.39 | 1,036,306 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
